Updates are available Correction dated 2021-12-05
Click to view Correction: https://doi.org/10.1007/s00330-021-08386-8
-
Authors
Auer, Timo Alexander http://orcid.org/0000-0002-5763-689X
Fehrenbach, Uli
Grieser, Christian
Penzkofer, Tobias
Geisel, Dominik
Schmelzle, Moritz
Müller, Tobias
Bläker, Hendrik
Seehofer, Daniel
Denecke, Timm
- License Information
-
More Information
Article History
Received: 26 August 2019
Revised: 3 February 2020
Accepted: 5 February 2020
First Online: 21 February 2020
Change Date: 5 December 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00330-021-08386-8
Compliance with ethical standards
:
: The scientific guarantor of this publication is Prof. Dr. med. Timm Denecke.
: Christian Grieser, Dominik Geisel, Daniel Seehofer, and Timm Denecke received honoraria, and travel expenses from Bayer Schering Pharma, Berlin, Germany in the past. All other authors who took part in this study declared that they do not have anything to disclose regarding funding or conflict of interest with respect to this manuscript.
: No complex statistical methods were necessary for this paper.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional review board approval of this retrospective study was obtained (No. EA2/016/14).
: Some study subject or cohorts have been previously reported in: Grieser C, Steffen IG, Kramme IB, et al <i>Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience. Eur Radiol. 2014;24(6):1339-48.</i>
: • Retrospective• Diagnostic or prognostic study• Performed at one institution
